CN101191141B - Fermentation culture medium for biologically synthesizing 7alpha, 15alpha-dihydroxyandrostenolone - Google Patents

Fermentation culture medium for biologically synthesizing 7alpha, 15alpha-dihydroxyandrostenolone Download PDF

Info

Publication number
CN101191141B
CN101191141B CN2006101185104A CN200610118510A CN101191141B CN 101191141 B CN101191141 B CN 101191141B CN 2006101185104 A CN2006101185104 A CN 2006101185104A CN 200610118510 A CN200610118510 A CN 200610118510A CN 101191141 B CN101191141 B CN 101191141B
Authority
CN
China
Prior art keywords
oil
organic nitrogen
content
carbon source
oils
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2006101185104A
Other languages
Chinese (zh)
Other versions
CN101191141A (en
Inventor
胡海峰
陶荣盛
张琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN2006101185104A priority Critical patent/CN101191141B/en
Publication of CN101191141A publication Critical patent/CN101191141A/en
Application granted granted Critical
Publication of CN101191141B publication Critical patent/CN101191141B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a fermentation medium for biosynthesis of 7 alpha-dihydroxy androstene alcohol ketone and 15 alpha-dihydroxy and rostene alcohol ketone by taking flax colletotrichum (Colletotrichum lini AS 3.4) as strain, consisting of organic nitrogen sources, carbon sources, inorganic salts and metal ions. The invention is characterized in that: the organic nitrogen sources are peptones, yeast extracts, beef extracts and yeast extract pastes. When a product I is synthesized by adoption of the fermentation medium of the invention, substrate feed concentration can reach 8 grams per liter (substrate weight/fermentation broth volume) and conversion ratio can reach 85 percent, thereby the invention can well solve the defects of low substrate feed concentration and low conversion ratio of the prior art, and then industrial production cost of the product I is reduced.

Description

Be used for biosynthesizing 7 α, the fermention medium of 15 alpha-dihydroxy-dihydrotestosterones
Technical field
The present invention relates to the mikrobe steroidal and transform substratum, be specifically related to a kind of biosynthesizing 7 α, fermentation culture medium for microbe of 15 alpha-dihydroxy-dihydrotestosterones of being used for.
Background technology
Steroidal class midbody often can be used for producing various clinically medicines.7 α, 15 alpha-dihydroxy-dihydrotestosterones (its structure is as shown in the formula I)
Be a kind of important steroidal midbody, can be used for multiple medicines such as synthetic lactone aldosterone receptor antagonist, diuretic(s) and gynecologic medicine.For example, I is the important intermediate of synthetic oral contraceptive Yasmin activeconstituents drospirenone.
Microbial transformation has critical role in steroid drugs synthetic, the important method of production steroid hormone and analogue thereof are gone up in several kinds of important steroidal microbial transformations reactions as hydroxylation, dehydrogenation and side chain degraded having become industry.The preparation of compound I is difficult to the method for chemistry synthetic, and is mainly synthetic by microbial transformation at present.
I can be synthetic through microbial transformation by dehydroepiandros-sterone (its structure is as shown in the formula II).It is the method that bacterial classification is converted into II I that Kieslich (German Patent No.DE 2746298 1979-04-19) has described with capsicum thorn dish spore (Colletotrichum phomoides ifo 5257); And (Angew.Chem.95 (5), 413-414,1983 such as Petzoldt; U.S.Patent No.44353271984-03-06) then having described with flax thorn dish spore (Colletotrichum lini cbs112.21) is the method that bacterial classification is converted into II I.But the concentration that feeds intake of two kinds of method substrates is very low, has only 1g/L, so transformation efficiency is very low, industrial cost is very high.Shang Ke etc. (Chinese medicine biotechnology applications magazine .2,30~34,2004) report flax thorn dish spores (Colletotrichum lini AS3.4486) can be converted into I with II; The very low 2g/L of having only of concentration but substrate feeds intake; Yield is low to have only 58.8%, and transformation efficiency is also lower, is about 70%.It is thus clear that the existing skill of changing a job can not be synthesized I efficiently, is badly in need of more efficiently conversion process, to improve the feed intake concentration and the transformation efficiency of substrate, to reduce production costs.
Figure S061B8510420061211D000021
Summary of the invention
For solving the problems of the technologies described above, the purpose of this invention is to provide that a kind of (Colletotrichum lini AS3.4486 is preserved in Chinese common micro-organisms culture presevation administrative center with flax thorn dish spore; Numbering AS3.4486) be bacterial classification; Biosynthesizing 7 α, the fermention medium of 15 alpha-dihydroxy-dihydrotestosterones comprises organic nitrogen source, carbon source, inorganic salt and metals ion; It is characterized in that described organic nitrogen source is peptone, yeast extract, Carnis Bovis seu Bubali cream, yeast extract paste.
The content of described organic nitrogen source is 6g/L~30g/L, preferred 10g/L~15g/L, more preferably 12g/L.
Preferably, described organic nitrogen source is a yeast extract.
Described carbon source is the polyose carbon source.
Said polyose carbon source is dextrin, maltodextrin, starch, Zulkovsky starch, Semen Maydis powder etc., is preferably maltodextrin and Zulkovsky starch, more preferably maltodextrin; Its content is 20g/L~50g/L, is preferably 35g/L.
Fermention medium of the present invention can also contain natural fats and oils.
Said natural fats and oils can be soya-bean oil, rapeseed oil, corn embryo oil, sunflower seed oil and cottonseed wet goods vegetables oil; Animal oil and fat such as lard, sheep oil, butter and fish oil; And phosphatide such as Yelkin TTS, POPG, phosphatidic acid; Its content is 0.5g/L~10g/L, and more excellent is 2g/L~5g/L, and optimum is 3g/L.
Also need add metals ions such as inorganic salt such as sylvite, phosphoric acid salt, ammonium salt and nitrate salt and magnesium in the substratum.
Different organic nitrogen sources are very big to the influence that transforms; The effects groundnut meal, soybean cake powder, cottonseed meal, dregs of beans, peptone, yeast extract, Carnis Bovis seu Bubali cream and nine kinds of organic nitrogen sources commonly used of yeast extract paste; The concentration of adding is 10g/L; The concentration that feeds intake of substrate is identical, transforms to finish the concentration (seeing accompanying drawing 1) that back HPLC detects product in each organic nitrogen source fermented liquid.Can find out that from figure organic nitrogen source adopts peptone, yeast extract, Carnis Bovis seu Bubali cream, yeast extract paste to be the content height of product, wherein the highest with yeast extract again.
Different carbon sources also have tangible influence to transforming; The effects carbon sources such as dextrin, maltodextrin, starch, Zulkovsky starch, Semen Maydis powder, sucrose, SANMALT-S, glucose and fructose; The concentration of adding is 30g/L; The concentration that feeds intake of substrate is identical, transforms to finish the concentration (seeing accompanying drawing 2) that back HPLC detects product in each carbon source through fermentation liquid.From figure can find out polyose carbon sources such as dextrin, maltodextrin, starch, Zulkovsky starch and Semen Maydis powder as carbon source the time bacterial classification conversion capability stronger; And with disaccharides such as sucrose and SANMALT-S, or monose carbon sources such as glucose and fructose during as carbon source conversion capability then lower.
In substratum, add the growth that a spot of natural fats and oils can promote thalline; Better promote the conversion of substrate in fermented liquid simultaneously; Experiment has been chosen multiple natural fats and oils such as soya-bean oil, rapeseed oil, corn embryo oil, sunflower seed oil, lard, fish oil, Yelkin TTS and POPG and has been added substratum respectively; Add to measure and be 3g/L; As contrast, the concentration that feeds intake of substrate is identical with the substratum that do not add natural fats and oils, transforms to finish the concentration (seeing accompanying drawing 3) that back HPLC detects product in each substratum.After scheming to find out all kinds of natural fats and oils of adding, transformation efficiency all is significantly improved.
When adopting fermention medium synthetic product I of the present invention, the substrate concentration that feeds intake can reach 8g/L (substrate weight/fermentating liquid volume), and transformation efficiency can arrive 85%.And when adopting the fermention medium synthetic product I of prior art, the substrate concentration that feeds intake has only 2g/L, and transformation efficiency is about about 70%.Therefore, through the present invention through the fermention medium of constituent optimization carry out the conversion of I synthetic can solve well the prior art substrate feed intake concentration low with the not high shortcoming of transformation efficiency, thereby reduce the industrial production cost of I.
Description of drawings
Fig. 1 representes the influence of different organic nitrogen sources to conversion reaction;
Fig. 2 representes the influence of different carbon sources to conversion reaction;
Fig. 3 has represented to add the promoter action of the substratum of natural fats and oils to conversion reaction.
Embodiment
Below come further to illustrate the present invention through concrete embodiment, but these embodiment are not construed as limiting the invention.Wherein, Yeast extract is that Hubei Angel Yeast Co.,Ltd produces, and peptone is that the East Sea, Shanghai pharmaceutical factory produces, and Carnis Bovis seu Bubali cream is that West China, Chengdu biochemical product factory produces; Yeast extract paste, dextrin, starch, Zulkovsky starch, Yelkin TTS are that Shanghai chemical reagents corporation of Chinese Medicine group produces; Groundnut meal is that Beijing Kang Mingwei substratum technology Ltd produces, and maltodextrin is that sea salt six is produced with starch chemical industry ltd, and Semen Maydis powder is that Zhucheng abundant rich powder process ltd produces; Sunflower seed oil is that vegetables oil ltd produced in praised in Qingdao, and soya-bean oil is that grain and oil Industrial Co., Ltd produced in praised in Shanghai.
Embodiment 1
Substratum
Slant medium: PDA substratum (200g potato liquor 1000ml, glucose 20g, agar 20g), 121 ℃ of sterilization 20min.
Seed culture medium: groundnut meal 10g/L; Dextrin 30g/L; KCl 1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Fermention medium: yeast extract 10g/L; Maltodextrin 35g/L; Sunflower seed oil 5g/L; KCl1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Conversion process: the inclined-plane that will inoculate bacterial classification places 28 ℃ of constant incubators, cultivates 6 days, obtains sophisticated spore; Sophisticated then spore inoculating shakes in the bottle in the 250ml that the 30ml seed culture medium is housed, and on 30 ℃, 230rpm shaking table, cultivates 3 days, obtains sophisticated seed; The 750ml that the seed that obtains is equipped with the 100ml fermention medium with 10% inoculum size access shakes in the bottle; Place 30 ℃, 230r/min shaking table to continue to cultivate 20 hours, add substrate, place 28 ℃, put bottle when the 240r/min shaking table continues to be converted into 48 hours with the amount of every liter of fermented liquid 8g substrate; Get fermented liquid 2ml and add 8ml methyl alcohol soaked overnight; The centrifuging and taking supernatant is analyzed with HPLC, adopts external standard method that sample is carried out quantitatively, and calculating transformation efficiency is 86.5%.The HPLC condition is a chromatographic instrument: Waters510 type high performance liquid chromatograph; Chromatographic column: C18 post; Detector: Waters996Photodiode Array Detector; Moving phase: methyl alcohol: water=50:50; Flow velocity: 0.8ml/min; Sample size: 5 μ l; Column temperature: room temperature.
Embodiment 2
Slant medium and seed culture medium are with embodiment 1.
Fermention medium: peptone 20g/L; Maltodextrin 30g/L; Lard 5g/L; KCl1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Conversion process is with embodiment 1, and last transformation efficiency is 85.1%.
Embodiment 3
Slant medium and seed culture medium are with embodiment 1.
Fermention medium: Carnis Bovis seu Bubali cream 30g/L; Dextrin 20g/L; Yelkin TTS 1g/L; KCl1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Conversion process is with embodiment 1, and last transformation efficiency is 85.3%.
Embodiment 4
Slant medium and seed culture medium are with embodiment 1.
Fermention medium: yeast extract 6g/L; Semen Maydis powder 50g/L; Yelkin TTS 2g/L; KCl1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Conversion process is with embodiment 1, and last transformation efficiency is 84.3%.
Embodiment 5
Slant medium and seed culture medium are with embodiment 1.
Fermention medium: yeast extract 12g/L; Maltodextrin 35g/L; Soya-bean oil 0.5g/L; KCl1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Conversion process is with embodiment 1, and last transformation efficiency is 84.1%.
Embodiment 6
Slant medium and seed culture medium are with embodiment 1.
Fermention medium: yeast extract 12g/L; Zulkovsky starch 35g/L; Soya-bean oil 5g/L; KCl1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Conversion process is with embodiment 1, and last transformation efficiency is 86.1%.
Embodiment 7
Slant medium and seed culture medium are with embodiment 1.
Fermention medium: yeast extract 12g/L; Maltodextrin 35g/L; Soya-bean oil 10g/L; KCl1g/L; (NH 4) 2HPO 41g/L; K 2HPO 41g/L; MgSO 46H 2O1g/L.PH5.5,121 ℃ of sterilization 20min.
Conversion process is with embodiment 1, and last transformation efficiency is 87.1%.
Embodiment 8
7.5L fermentor tank transforms synthetic I
Each substratum is with embodiment 4
Conversion process: the inclined-plane that will inoculate bacterial classification places 28 ℃ of constant incubators, cultivates 6 days, obtains sophisticated spore; Sophisticated then spore inoculating shakes in the bottle in the 750ml that the 100ml seed culture medium is housed, and on 30 ℃, 230rpm shaking table, cultivates 3 days, obtains sophisticated seed; The seed that obtains inserts with 10% inoculum size in the fermention medium of 4.5L (being loaded in the 7.5L fermentor tank); 30 ℃ of temperature, air flow 0.4VVM, rotating speed 180rpm cultivates.Cultivate after 20 hours, add substrate with the amount of every liter of fermented liquid 8g substrate, temperature transfers to 28 ℃ and begins to transform then, in conversion process, controls dissolved oxygen through increasing rotating speed more than 20% saturation ratio with air flow.Confirm transforming degree with thin layer chromatography in the conversion process, analytical procedure: take a morsel conversion fluid in centrifuge tube, add equal-volume ETHYLE ACETATE; Behind ultrasonic cell-break in 4000r/min, 25 ℃ of centrifugal 6min; Check plate on taking a morsel, developping agent is: trichloromethane: absolute ethyl alcohol=10:1 (V/V), spray the post-heating colour developing with 10% sulphuric acid soln; Observe the spot situation, confirm transforming degree.Product stops accumulation during by 48 hours, finishes to transform to put jar, and it is 85.4% that HPLC analyzes transformation efficiency.

Claims (3)

1. one kind is bacterial classification with flax thorn dish spore AS 3.4486; Biosynthesizing 7 α, the fermention medium of 15 alpha-dihydroxy-dihydrotestosterones comprises organic nitrogen source, carbon source, inorganic salt, metals ion and natural fats and oils; It is characterized in that described organic nitrogen source is a yeast extract;
The content of described organic nitrogen source is 10g/L~15g/L;
Described carbon source is the polyose carbon source, and said polyose carbon source is dextrin, starch or Semen Maydis powder; Its content is 20g/L~50g/L;
Said natural fats and oils is soya-bean oil, rapeseed oil, corn embryo oil, sunflower seed oil, Oleum Gossypii semen, lard, sheep oil, butter, fish oil, Yelkin TTS, POPG or phosphatidic acid;
The content of said natural fats and oils is 0.5g/L~10g/L.
2. fermention medium as claimed in claim 1 is characterized in that, said polyose carbon source is for being maltodextrin or Zulkovsky starch, and its content is 35g/L.
3. fermention medium as claimed in claim 1 is characterized in that, the content of said natural fats and oils is 2g/L~5g/L.
CN2006101185104A 2006-11-20 2006-11-20 Fermentation culture medium for biologically synthesizing 7alpha, 15alpha-dihydroxyandrostenolone Expired - Fee Related CN101191141B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2006101185104A CN101191141B (en) 2006-11-20 2006-11-20 Fermentation culture medium for biologically synthesizing 7alpha, 15alpha-dihydroxyandrostenolone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2006101185104A CN101191141B (en) 2006-11-20 2006-11-20 Fermentation culture medium for biologically synthesizing 7alpha, 15alpha-dihydroxyandrostenolone

Publications (2)

Publication Number Publication Date
CN101191141A CN101191141A (en) 2008-06-04
CN101191141B true CN101191141B (en) 2012-05-09

Family

ID=39486342

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006101185104A Expired - Fee Related CN101191141B (en) 2006-11-20 2006-11-20 Fermentation culture medium for biologically synthesizing 7alpha, 15alpha-dihydroxyandrostenolone

Country Status (1)

Country Link
CN (1) CN101191141B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102477454B (en) * 2010-11-30 2014-11-05 上海来益生物药物研究开发中心有限责任公司 Preparation method for pyrone compound
CN102599433B (en) * 2012-04-05 2013-08-07 安徽燕之坊食品有限公司 Production method for coarse-cereal artificial rice
CN102757998A (en) * 2012-05-28 2012-10-31 江南大学 Method for preparing 7alpha, 15alpha-dihydroxy androstenone by flowingly addition of hydrogen peroxide
CN102757997A (en) * 2012-05-28 2012-10-31 江南大学 Method for preparing 7alpha, 15alpha-dihydroxy androstenone by pre-inducing substrate
CN103060201A (en) * 2012-11-01 2013-04-24 江南大学 Strain capable of efficiently converting DHEA (dehydroepiandrosterone) into 3 beta, 7 alpha and 15 alpha-trihydroxy androstane-5-alkene-17-ketone obtained by compound mutation screening
CN104673677A (en) * 2014-04-08 2015-06-03 丽江映华生物药业有限公司 Colletotrichum lini strain LJYH20130405-1 for steride fermentation as well as application technology thereof
CN104004802A (en) * 2014-06-03 2014-08-27 济南汇隆生物科技有限公司 Cottonseed fine meal for fermentation and preparation method thereof
CN106906250A (en) * 2017-04-18 2017-06-30 四川龙蟒福生科技有限责任公司 A kind of fermentation process for producing S abscisic acids

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002218970A (en) * 2001-01-24 2002-08-06 Kikkoman Corp Method for producing liquid koji
WO2005030976A2 (en) * 2003-09-26 2005-04-07 Biosynergy Gmbh Method for producing a carotinoid-containing biomass

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002218970A (en) * 2001-01-24 2002-08-06 Kikkoman Corp Method for producing liquid koji
WO2005030976A2 (en) * 2003-09-26 2005-04-07 Biosynergy Gmbh Method for producing a carotinoid-containing biomass

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
I. taxonomy et al.Tiacumicins, a novel complex of 18-membered macrolide antibiotics.<The journal of antibiotics>.1987,第40卷(第5期), *
I.taxonomyetal.Tiacumicins a novel complex of 18-membered macrolide antibiotics.<The journal of antibiotics>.1987

Also Published As

Publication number Publication date
CN101191141A (en) 2008-06-04

Similar Documents

Publication Publication Date Title
CN101191141B (en) Fermentation culture medium for biologically synthesizing 7alpha, 15alpha-dihydroxyandrostenolone
Demain REVIEWS: The business of biotechnology
Burg et al. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation
Woodruff Natural products from microorganisms
CN109439701B (en) Method for preparing ergothioneine by biosynthesis and fermentation medium
CN104342390B (en) A kind of Sinorhizobium meliloti strain and combinations thereof and application
HU201973B (en) Process for producing avermeclin beta derivatives
Boeck et al. A9145, a new adenine-containing antifungal antibiotic: fermentation
US4594248A (en) CL-1577-B4 compound, its production and use
Bhalkar et al. Solid state fermentation of soybean waste and an up-flow column bioreactor for continuous production of camptothecine by an endophytic fungus Fusarium oxysporum
CN101457250B (en) Method for synthesizing betulic acid from betulin through microbial cell bioconversion
CN101397540B (en) Culture medium for producing staurosporine and method thereof
CN104878059A (en) Method for preparing S-adenosylmethionine
Horgan et al. Pharmaceutical and chemical commodities from fungi
JPH06501026A (en) Novel immunosuppressant derived from Streptomyces bregensis
KR101716879B1 (en) Method Producing Daptomycin Using Decanoyl Glyceride
CN104805150A (en) Method for preparing tetrahydrojiatrorrhizine by utilizing microbial conversion
Boumehira et al. Bioprocess Development for β-and γ-rubromycin Production: A Human Telomerase Inhibitors, by Streptomyces sp. ADR1
CN109371073B (en) Method for producing non-viable bacteria element by fermentation
Loboda et al. Biosynthesis of polyene antibiotics and phytohormones by Streptomyces netropsis IMV Ac-5025 under the action of exogenous isopentenyladenosine.
CN115894307B (en) Isonitrile compound, preparation method thereof and application thereof in preparation of antibacterial drugs
JPH0374388A (en) Novel microbiologically transformed l-683, 590 products
JPH0695947B2 (en) Ethylated avermectin
GB2278781A (en) Unguinol and analogs as animal growth promoters
WO2007073235A1 (en) Method for producing a biologically active product exhibiting a hepatoprotective action

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120509

Termination date: 20151120

EXPY Termination of patent right or utility model